Ellagic Acid

Ellagic Acid

SCHEMBL30475160

O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
MAPT P10636 4/20 1.00
HPGD P15428 3/20 1.00
BLM P54132 3/20 1.00
APEX1 P27695 3/20 1.00
RECQL P46063 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
POLB P06746 3/20 1.00
GAA P10253 3/20 1.00
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
PKLR P30613 2/20 1.00
GALNT2 Q10471 2/20 1.00
CA12 O43570 2/20 1.00
CA1 P00915 2/20 1.00
CA7 P43166 2/20 1.00
CA9 Q16790 2/20 1.00
CA13 Q8N1Q1 2/20 1.00
LMNA P02545 2/20 1.00
MAPK1 P28482 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ellagic Acid SCHEMBL20429 1.00 KDM4E (1.00) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL29439360 1.00 KDM4E (1.00) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL1645767 1.00 KDM4E (1.00) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL2639621 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL21590140 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL8686551 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL177722 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL8686557 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL8686700 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1
Ellagic Acid SCHEMBL9146254 0.98 KDM4E (0.96) KDM4EMAPTHPGDBLMAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025201585-A1 DEVICE AND METHOD FOR APPLYING MATRIX MATERIAL FOR MATRIX-ASSISTED IONIZATION Bruker Daltonics GmbH & Co. KG (DE) 2025-10-02 WO disclosed
US-20250041318-A1 STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF COMMUNITREAT LTD. (IL) 2025-02-06 US disclosed
EP-4440698-A1 STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF Communitreat Ltd. (IL) 2024-10-09 EP disclosed
CN-118742312-A Sterilant compositions, kits and methods of use thereof 柯姆尼治疗公司 2024-10-01 CN disclosed
WO-2023100184-A1 STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF COMMUNITREAT LTD. (IL) 2023-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250041318-A1 STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF NASP, ACR, ALPG KDM4E 876/4885MAPT 3443/4885HPGD 3778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.